ArticleMolecular carcinogenesis2024

Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer.

Takashi Furusawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.